Results 61 to 70 of about 375 (114)

Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study. [PDF]

Lancet HIV
Eron JJ, Little SJ, Crofoot G, Cook P, Ruane PJ, Jayaweera D, VanderVeen LA, DeJesus E, Zheng Y, Mills A, Huang H, Waldman SE, Ramgopal M, Gorgos L, Collins SE, Baeten JM, Caskey M.   +16 more
europepmc   +1 more source

Antibody evasion properties of SARS-CoV-2 Omicron sublineages. [PDF]

Nature, 2022
Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, Wang M, Luo Y, Yu J, Chu H, Chik KK, Yuen TT, Yin MT, Sobieszczyk ME, Huang Y, Yuen KY, Wang HH, Sheng Z, Ho DD.   +18 more
europepmc   +1 more source

LP.8.1-directed COVID-19 mRNA vaccines durably boost neutralizing antibodies and mitigate ancestral immune imprinting. [PDF]

PLoS Pathog
Mellis IA, Wu M, Hong H, Bowen A, Daniel K, Gherasim C, Pierce VM, Yin MT, Gordon A, Guo Y, Ho DD.   +10 more
europepmc   +1 more source

TAIMS: Transaction Artificial Intelligence Monitoring Systems Framework

Money laundering encompasses a crucial risk to Financial Institutions (FIs), requiring them to adhere to Anti-money Laundering (AML) practices such as Transaction Monitoring (TM). Recently, increasing attention has been given in applying Artificial Intelligence (AI) and Machine Learning (ML) to improve the efficiency of Transaction Monitoring Systems ...
Wennström, Ella, Lustig Lindström, Ebba   +1 more
openaire   +1 more source

Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC. [PDF]

Cell Rep
Wang Q, Guo Y, Mellis IA, Wu M, Mohri H, Gherasim C, Valdez R, Purpura LJ, Yin MT, Gordon A, Ho DD.   +10 more
europepmc   +1 more source

Commentary on the Trial of Antihypertensive Interventions and Management (TAIM) Study [PDF]

American Journal of Hypertension, 1992
openaire   +1 more source

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1. [PDF]

Cell Host Microbe
Wang Q, Guo Y, Bowen A, Mellis IA, Valdez R, Gherasim C, Gordon A, Liu L, Ho DD.   +8 more
europepmc   +1 more source

Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2. [PDF]

Nat Commun
Wang Q, Guo Y, Casner RG, Yu J, Nair MS, Ho J, Reddem ER, Mellis IA, Wu M, Tzang CC, Hong H, Huang Y, Shapiro L, Liu L, Ho DD.   +14 more
europepmc   +1 more source